Safety and Feasibility of Antegrade Cholangiopancreatoscopy‐Guided Laser Dissection and Ablation for Pancreaticobiliary Jejunal Anastomotic Stricture (With Video)
Digestive Endoscopy · 2026-06 · 38 (6)
DOI: 10.1111/den.70192 ↗Kurz gefasst
Video/Audio in der Zeitschrift Digestive Endoscopy, online erschienen am 31.05.2026. Verfasst von Takeshi Ogura und 13 weiteren Autor:innen. Beteiligte Einrichtung: Pancreatobiliary Advanced Medical Center, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan. Hauptthemen laut MEDLINE: Laser Therapy, Postoperative Complications, Pancreaticojejunostomy, Pancreaticoduodenectomy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hepaticojejunostomy anastomotic stricture (HJS) and pancreaticojejunostomy anastomotic stricture (PJS) are late adverse events that can occur after pancreaticoduodenectomy. Although endoscopic and percutaneous interventions are available, recurrence remains common because of residual fibrotic tissue. Cholangiopancreatoscopy‐guided laser dissection or ablation (CPL) has been reported for benign pancreatobiliary strictures; however, evidence regarding antegrade CPL for HJS/PJS is limited. This study aimed to evaluate the safety and feasibility of antegrade CPL for HJS/PJS. This retrospective study included consecutive patients with HJS or PJS who underwent antegrade CPL. The primary outcome was the incidence of adverse events related to antegrade CPL. Antegrade CPL was performed in 19 patients after exclusion of 1 malignant stricture. Technical success was achieved in all cases. Mean procedure time was 21 min. Complete stricture resolution was observed in 73.7% of patients, and partial resolution in 26.3%. Contrast passage from the duct to the intestine was confirmed in all patients after CPL. Antegrade CPL for HJS/PJS showed a favorable short‐term safety profile, with no severe CPL‐related adverse events, while maintaining technical feasibility and achieving endoscopic stricture resolution in all treated patients. Further prospective studies with longer follow‐up are warranted to confirm its safety and durability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pancreatobiliary Advanced Medical Center, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan.
- 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
- Endoscopy Center, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan.
- Gastroenterology, Viet Nam National Cancer hospital, Ha Noi, Vietnam.
- Gastroenterology, Calmette Hospital, Phnom Penh, Cambodia.
ORCID-Profile: Takeshi Ogura, Atsushi Okuda, Yoshitaro Yamamoto, Hiroki Nishikawa
Zitieren
APA
Ogura, T., Osaka, K., Ueno, S., Okuda, A., Nishioka, N., Matsuno, J., Hattori, N., Nakamura, J., Bessho, K., Kanadani, T., Yamamoto, Y., Trong, N. N., Ly, K. C., & Nishikawa, H. (2026). Safety and Feasibility of Antegrade Cholangiopancreatoscopy‐Guided Laser Dissection and Ablation for Pancreaticobiliary Jejunal Anastomotic Stricture (With Video). Digestive Endoscopy, 38(6). https://doi.org/10.1111/den.70192
Vancouver
Ogura T, Osaka K, Ueno S, Okuda A, Nishioka N, Matsuno J, et al. Safety and Feasibility of Antegrade Cholangiopancreatoscopy‐Guided Laser Dissection and Ablation for Pancreaticobiliary Jejunal Anastomotic Stricture (With Video). Digestive Endoscopy. 2026;38(6). doi:10.1111/den.70192
BibTeX
@article{Ogura2026,
author = {Ogura, Takeshi and Osaka, Kentaro and Ueno, Saori and Okuda, Atsushi and Nishioka, Nobu and Matsuno, Jun and Hattori, Nobuhiro and Nakamura, Junichi and Bessho, Kimi and Kanadani, Takafumi and Yamamoto, Yoshitaro and Trong, Nga Nguyen and Ly, Kim Chhun and Nishikawa, Hiroki},
title = {Safety and Feasibility of Antegrade Cholangiopancreatoscopy‐Guided Laser Dissection and Ablation for Pancreaticobiliary Jejunal Anastomotic Stricture (With Video)},
journal = {Digestive Endoscopy},
year = {2026},
volume = {38},
number = {6},
doi = {10.1111/den.70192}
}
EUVIMED